PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.
about
Role of the PD-1 pathway in the immune responseTransplantation tolerance and its outcome during infections and inflammationTempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cellsThe CD8 T-cell response during tolerance induction in liver transplantationInfection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft modelPD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancyAlloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury.LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathwayPD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue.The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation.Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patientsThe role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host diseaseTIM4 Regulates the Anti-Islet Th2 Alloimmune ResponseThe novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.Cardiac allograft vasculopathy: a donor or recipient induced pathology?The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance.Influence of Interferon-γ Deficiency in Immune Tolerance Induced by Male Islet TransplantationInteractions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants.Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection.CD28 family and chronic rejection: "to belatacept...And beyond!".The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation.Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types.Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats.Harnessing negative T-cell costimulatory pathways to promote engraftment.Immune Tolerance for Autoimmune Disease and Cell TransplantationDivergent role of donor dendritic cells in rejection versus tolerance of allografts.PD-1/PD-L1 Interaction Maintains Allogeneic Immune Tolerance Induced by Administration of Ultraviolet B-Irradiated Immature Dendritic Cells.Expression and function of PDCD1 at the human maternal-fetal interface.PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways.Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy.Bacterial infections, alloimmunity, and transplantation tolerance.T-cell co-stimulatory blockade in transplantation: two steps forward one step back!Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.T Cell Cosignaling Molecules in Transplantation.
P2860
Q26828748-C9FA97BB-E2E5-4B29-B58A-FFE722046B75Q26829817-DBCC5B36-0119-4D89-BCF7-9DE68911B45DQ26851647-4A4477D0-1BF7-475F-90CE-16DD6827DF58Q28079184-6B45D8C3-88B6-4E0D-8B71-7EF2E9575A02Q33767212-7F0F84C9-6540-43AB-9496-2F3206917A4FQ33893319-B44508B3-CFA9-4D0B-884D-CA72CDA49568Q33967995-B35ED011-CC1B-4725-A744-46457B46BD83Q34164098-0BA1742F-4AB7-4555-A5FB-763B5CA36B9FQ34172252-109FA258-FCD4-4147-A7B7-DC45C24153ECQ34193534-F01BA6BF-271F-4894-9025-AE031AECC9EAQ34593527-4D0478A7-D5FF-4D37-9AE4-115B68C35BD6Q34597955-285AA507-9A54-4852-A212-DBC9A59E0259Q34598808-5058F36B-0349-437E-8BC0-9088ECF93C0FQ34639457-E859667B-3DCB-40DC-9213-75648AEC4460Q34673038-F6695C83-C520-40E9-9208-A9BDFAFED17DQ34791435-67538438-43A8-4D8A-9DAD-617EC9B42959Q35118927-6B622C1E-7AC6-4CF6-AB4C-94D75F63A9CBQ35244151-79B14BA2-A934-4607-A04C-39304F81B91FQ35403407-3237022C-12FB-4218-9560-8C7A0ECCF6DAQ35745499-0A9878FE-9197-4FF6-9DD8-4E545651ED3DQ35776458-55A84A08-C26E-44BE-8B22-58F4C12BC928Q35829453-04148E7E-CC60-4D1F-A59F-53A34D935DBAQ36037639-256313E0-7425-4B5D-9164-009FC7A409E4Q36303692-E1AF8D91-11D1-49E4-BB6F-9A83A23927F6Q36327666-65F95326-74DF-4D07-A9B0-9575FF91D6D7Q36939402-FFB4CC11-2919-4E10-A373-F8D86C66732CQ36983949-F7DD6D09-982C-4B9A-8655-78B4FDAC84BEQ36985976-383728B5-F5CC-472B-8E78-64E0751F170CQ37030982-F47CD056-82C6-4804-808B-D9721ABDF082Q37099107-991951D9-6C3A-49C9-9D65-CE6CE37499A4Q37123243-95CA996E-331E-4A5B-8C85-9A8674CF38A8Q37172083-A5965729-D41A-43AA-B737-FE00217D83AFQ37208445-6FD1803B-4F30-4E71-B85F-875B2A7E0E22Q37228818-3CA343DD-45DB-465D-B105-2C01BA9FAB5BQ37277855-022BA302-21FB-4B1B-9129-D151ED2FC409Q37393109-BF31D561-7E31-4005-BF50-D2A8E4ED73D7Q37815276-3926E405-9FCC-43D2-9776-77716B5AA21FQ38148197-3F90A26E-5A93-4A29-9A1B-D8DF380E7A04Q38339535-6DFE3B8E-F63D-4EAB-910B-4F689D15497AQ38837473-2DFFCCD6-FDD6-408C-8DB8-0CFED25021B8
P2860
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
PDL1 is required for periphera ...... m chronic allograft rejection.
@ast
PDL1 is required for periphera ...... m chronic allograft rejection.
@en
PDL1 is required for periphera ...... m chronic allograft rejection.
@nl
type
label
PDL1 is required for periphera ...... m chronic allograft rejection.
@ast
PDL1 is required for periphera ...... m chronic allograft rejection.
@en
PDL1 is required for periphera ...... m chronic allograft rejection.
@nl
prefLabel
PDL1 is required for periphera ...... m chronic allograft rejection.
@ast
PDL1 is required for periphera ...... m chronic allograft rejection.
@en
PDL1 is required for periphera ...... m chronic allograft rejection.
@nl
P2093
P2860
P1476
PDL1 is required for periphera ...... m chronic allograft rejection.
@en
P2093
Ana Maria Waaga
Antje Habicht
David M Rothstein
Hideo Yagita
Katsunori Tanaka
Kazuhiro Yamaura
Martin Grimm
Miyuki Azuma
Mohamed H Sayegh
Monica J Albin
P2860
P304
P356
10.4049/JIMMUNOL.179.8.5204
P407
P577
2007-10-01T00:00:00Z